Product Program year 2021 Source: CMS Open Payments

Alphanate

Biological Hematology

NDC 68516-4609-2

Open in the dashboard

General payments

$35,266

115 payments

Research payments

$486,293

13 payments

Through program year 2021, $35,266 in general payments and $486,293 in research payments were reported against Alphanate (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2021 General $10,928 6
2020 General $8,680 20
2020 Research $369,560 5
2019 General $15,658 89
2019 Research $116,733 8

Breakdown

Who paid General payments · program years 2019–2021
  1. Grifols Shared Services North America, Inc. $22,876 23 payments
  2. Grifols Therapeutics LLC $8,543 28 payments
  3. Grifols USA, LLC $3,846 64 payments
Top recipients General payments · program year 2021
  1. James Bussel Pediatric Hematology-Oncology · New York, NY $4,500 41% · 1 payment
  2. Craig Kessler Hematology & Oncology · Washington, DC $4,188 38% · 2 payments
  3. Guy Young Pediatric Hematology-Oncology · Bozeman, MT $2,200 20% · 1 payment
  4. Steven Rosinski Hematology & Oncology · Bullhead City, AZ $21 <1% · 1 payment
  5. Michael Graham Pediatric Hematology-Oncology · Las Vegas, NV $19 <1% · 1 payment

Each share is of general payments naming this product in 2021.

Specialties paid General payments · program year 2021
  1. Pediatric Hematology-Oncology Pediatrics $6,719 61% · 3 practitioners
  2. Hematology & Oncology Internal Medicine $4,209 39% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2021
  1. New York $4,500 41% · 1 recipient
  2. District of Columbia $4,188 38% · 1 recipient
  3. California $2,200 20% · 1 recipient
  4. Washington $21 <1% · 1 recipient
  5. Arizona $19 <1% · 1 recipient

Each share is of general payments naming this product in 2021 where a state was reported.

115 general · 13 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record